News

Open Call for Applications – European Defence Innovation Scheme (EUDIS) Business Accelerator and Matchmaking programme

Published on | 11 months ago

Programmes
Cybersecurity Defence EDF NATO-EDA DIRS

The European Commission has launched an open call for applications for two new initiatives under the EU Defence Innovation Scheme (EUDIS): the EUDIS Business Accelerator and EUDIS Matchmaking.

EUDIS Business Accelerator

An intensive 8-month acceleration programme designed for European startups and scale-ups. Participants will benefit from:

  • Six dedicated bootcamps across Europe’s defence ecosystems,                                         
  • Tailored training & coaching from industry experts,
  • Exclusive networking opportunities with defence stakeholders,
  • €65,000 seed-financing voucher for selected companies.

 

Apply by April 27More information & application

 

EUDIS Matchmaking

A tailored matchmaking initiative bringing together the whole European defence innovation ecosystem, including innovators, investors, end-users, and corporates. The programme includes:

  • Exclusive onsite & online matchmaking events – including at key deep-tech and defence conferences such as Latitude 59 (May, Tallinn) and Paris Air Show (June, Paris),
  • Personalized support from a dedicated community manager,
  • Enhanced access to capital & strategic partnerships,
  • Community-building activities.

 

Continuous open call – early applications encouragedMore information & application

 

If you’d like to find out more, join the Info Webinars:

EUDIS Matchmaking Webinar – April 8Register here

EUDIS Business Accelerator Webinar – April 10Register here

 

We invite you to seize this opportunity to accelerate your growth, access funding, and integrate into the European defence innovation ecosystem.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1838 articles available search in articles 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.